A testing strategy capable of detecting anti-CMV T cell immunity posttransplantation could be used to guide decisions about the need for continuing anti-viral prophylaxis.See article by Kumar et al on page 1214.
No takes yet. Share an insight, caveat, or question.
Danziger‐Isakov et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: